Hohimer Wealth Management »

Cognition Therapeutics shares owned by Hohimer Wealth Management

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Hohimer Wealth Management from 13F filings

Historical chart of Hohimer Wealth Management investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Hohimer Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Hohimer Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $410k 225k 1.82

More positions owned by Hohimer Wealth Management

Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Broadcom (AVGO)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Shell Spon Ads (SHEL)
Visa Com Cl A (V)
Ameriprise Financial (AMP)
Ares Management Corporation Cl A Com Stk (ARES)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Broad Usd High (USHY)

View all positions for Hohimer Wealth Management

Top funds holding Cognition Therapeutics

AIGH Capital Management
Vanguard Group
AWM Investment Company
Alyeska Investment Group
Timelo Investment Management
Corsair Capital Management
Hohimer Wealth Management
Kestra Advisory Services
American Financial Group
Geode Capital Management
CM Management
Sigma Planning
Commonwealth Equity Services
Bridgeway Capital Management
Mercer Global Advisors

View all funds holding Cognition Therapeutics